CYTOR and breast cancer: It has further been reported that, together with CYTOR, and MAPTAS1, MIR4458HG was an independent prognostic factor in breast cancer patients (10.21203/rs.2.24062/v1, preprint), with high expression associated with lower hazard ratios.